Abstract:Background: Osteoarthritis (OA) is a prevalent chronic joint disease with an obscure underlying molecular signature. Cuproptosis plays a crucial role in various biological processes. However, the association between cuproptosis-mediated immune infifiltration and OA progression remains unexplored. Therefore, this study elucidates the pathological process and potential mechanisms underlying cuproptosis in OA by constructing a columnar line graph model and performing consensus clustering analysis. Methods: Gene expression profifile datasets GSE12021, GSE32317, GSE55235, and GSE55457 of OA were obtained from the comprehensive gene expression database. Cuproptosis signature genes were screened by random forest (RF) and support vector machine (SVM). A nomogram was developed based on cuproptosis signature genes. A consensus clustering was used to distinguish OA patients into different cuproptosis patterns. To quantify the cuproptosis pattern, a principal component analysis was developed to generate the cuproptosis score for each sample. Single-sample gene set enrichment analysis (ssGSEA) was used to provide the abundance of immune cells in each sample and the relationship between these significant cuproptosis signature genes and immune cells.To quantify the cuproptosis pattern, a principal component analysis technique was developed to generate the cuproptosis score for each sample. Cuproptosis-related genes were extracted and subjected to differential expression analysis to construct a disease prediction model and confifirmed by RT-qPCR. Results: Seven cuproptosis signature genes were screened (DBT, LIPT1, GLS, PDHB, FDX1, DLAT, and PDHA1) to predict the risk of OA disease. A column line graph model was developed based on these seven cuproptosis signature genes, which may assist patients based on decision curve analysis. A consensus clustering method was used to distinguish patients with disorder into two cuproptosis patterns (clusters A and B). To quantify the cuproptosis pattern, a principal component analysis technique was developed to generate the cuproptosis score for each sample. Furthermore, the OA characteristics of patients in cluster A were associated with the inflflammatory factors IL-1b, IL-17, IL-21, and IL-22, suggesting that the cuproptosis signature genes play a vital role in the development of OA. Discussion: In this study, a risk prediction model based on cuproptosis signature genes was established for the fifirst time, and accurately predicted OA risk. In addition, patients with OA were classifified into two cuproptosis molecule subtypes (clusters A and B); cluster A was highly associated with Th17 immune responses, with higher IL-1b, IL-17, and IL-21 IL-22 expression levels, while cluster B had a higher correlation with cuproptosis. Our analysis will help facilitate future research related cuproptosis-associated OA immunotherapy. However, the specifific mechanisms remain to be elucidated.

Exploring the cuproptosis-related molecular clusters in the peripheral blood of patients with amyotrophic lateral sclerosis

Mutational and Transcriptional Profiling of Cuproptosis-Associated Genes in Amyotrophic Lateral Sclerosis

Novel Cuproptosis Metabolism-Related Molecular Clusters and Diagnostic Signature for Alzheimer’s Disease

Identification of cuproptosis-related genes in Alzheimer's disease based on bioinformatic analysis

Machine Learning Screening for Parkinson’s Disease-Related Cuproptosis-Related Typing Development and Validation and Exploration of Personalized Drugs for Cuproptosis Genes

Diagnostic models and predictive drugs associated with cuproptosis hub genes in Alzheimer's disease

Developing a novel immune infiltration-associated mitophagy prediction model for amyotrophic lateral sclerosis using bioinformatics strategies

Construction and validation of a bioinformatics‐based screen for cuproptosis‐related genes and risk model for Alzheimer's disease

Identification of Cuproptosis Clusters and Integrative Analyses in Parkinson's Disease

Identification of cuproptosis-related molecular subtypes and a novel predictive model of COVID-19 based on machine learning

Identification of the Cuproptosis-Related Cerna Network and Risk Model in Acute Ischemic Stroke by Integrated Bioinformatics Analysis

Evaluation the Role of Cuproptosis-Related Genes in the Pathogenesis, Diagnosis and Molecular Subtypes Identification of Atherosclerosis

Risk factor prediction and immune correlation analysis of cuproptosis-related gene in osteoarthritis

A cuproptosis-based prognostic model for predicting survival in low-grade glioma

Identification of Regulatory Factors and Prognostic Markers in Amyotrophic Lateral Sclerosis

Identification of key genes for cuproptosis in carotid atherosclerosis

Significance of Cuproptosis-related Genes in Immunological Characterization, Diagnosis and Clusters Classification in Parkinson's Disease.

Identification and Experimental Verification of a Cuproptosis-Associated Gene Signature for Overall Survival Prediction in Patients with Non-Small Cell Lung Cancer

Identification of cuproptosis-related subtypes, characterization of immune microenvironment infiltration, and development of a prognosis model for osteoarthritis

Identification and immunological characterization of cuproptosis-related molecular clusters in ulcerative colitis

A Novel Cuproptosis-Related Gene Signature Can Predict Prognosis in Acute Myeloid Leukemia: Bioinformatics Analysis and Experimental Validation